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ABSTRACT:
Castrate-Resistant Prostate Cancer (CRPC) is characterized by persistent 
androgen receptor-driven tumor growth in the apparent absence of systemic 
androgens. Current evidence suggests that CRPC cells can produce their own 
androgens from endogenous sterol precursors that act in an intracrine manner to 
stimulate tumor growth. The mechanisms by which CRPC cells become steroidogenic ????????????????????????????????? ??????????????????? ????????????????????????????????
the elevated cholesterol phenotype of CRPC and the TERE1 tumor suppressor protein, 
a prenyltransferase that synthesizes vitamin K-2, which is a potent endogenous ligand 
for the SXR nuclear hormone receptor. We show that 50% of primary and metastatic 
prostate cancer specimens exhibit a loss of TERE1 expression and we establish a 
correlation between TERE1 expression and cholesterol in the LnCaP-C81 steroidogenic 
cell model of the CRPC. LnCaP-C81 cells also lack TERE1 protein, and show elevated 
cholesterol synthetic rates, higher steady state levels of cholesterol, and increased 
expression of enzymes in the de novo cholesterol biosynthetic pathways than the 
non-steroidogenic prostate cancer cells. C81 cells also show decreased expression 
of the SXR nuclear hormone receptor and a panel of directly regulated SXR target ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
the CRPC phenotype: SXR might coordinately regulate this phenotype. Moreover, 
TERE1 controls synthesis of vitamin K-2, which is a potent endogenous ligand for 
SXR activation, strongly suggesting a link between TERE1 levels, K-2 synthesis and 
SXR target gene regulation. We demonstrate that following ectopic TERE1 expression 
or induction of endogenous TERE1, the elevated cholesterol levels in C81 cells are 
reduced. Moreover, reconstitution of TERE1 expression in C81 cells reactivates SXR 
and switches on a suite of SXR target genes that coordinately promote both cholesterol ???????????????????????????????????????????????????????????????????????????????????
K-2 levels resulting in reduced transcription of SXR target genes.  We propose that 
TERE1 controls the CPRC phenotype by regulating the endogenous levels of Vitamin 
K-2 and hence the transcriptional control of a suite of steroidogenic genes via the 
SXR receptor. These data implicate the TERE1 protein as a previously unrecognized ??????????????????????????????????????????????????????????????????????????????????
of the CRPC phenotype.
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INTRODUCTION 
Prostate cancer remains the most common male 
malignancy and the second most common form of male 
cancer death [1-3]. The common characteristic of the 
disease through its clinical progression is androgen 
receptor activation, which is initially accomplished by 
systemic androgens. Abrogation of this pathway is a 
common clinical treatment, which becomes ineffective 
as tumors overcome castration induced levels of 
systemic androgens by autocrine stimulation of self 
produced androgens or androgen receptor activation 
through mutations (receptor promiscuity to ligands or 
constitutive activation) [4]. Although the activation of 
androgen bio-synthetic pathway enzymes in tumor cells 
has been demonstrated recently [5-9], the metabolism of 
baseline hormone precursors such as cholesterol are less 
well understood throughout the progression of prostate 
cancer. Fig. 1A lists some features of Castrate Resistant 
Prostate cancers [4, 10, 11]. Both primary tumors and 
cell line models are characterized by aggressive growth, 
and elevated levels of intracellular cholesterol [12] which 
can cause altered growth signaling [13, 14], inhibition 
of apoptosis [15-19], and provide intracrine precursors 
for steroidogenesis, resulting in activation of androgen 
receptor driven target genes associated with proliferation 
[5-9, 20] . 
Cellular cholesterol levels are normally highly 
regulated via a complex interplay between several 
???????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????
and steroid hormones [21, 22]. Generally the SREBP 
transcriptional regulator proteins activate genes for 
????????????????????????????????????????????????????
????????????????????????????????????????????????????????????
also regulate different aspects of fatty acid metabolism 
??????????????????????????????????????????????????????????
steroid and xenobiotic receptor, or activated by oxysterols 
derived from the cholesterol pathway or by fatty acids [23-
?????????????????????????????????????????????????????????
such as APOAI, APOE, and the transporters such as the 
ATP binding cassette proteins ABC-A1, -G1, -G4, -G5, 
??????????????????????????????????????????????????????
???? ????? ??????????????????????? ?????? ?????????????
be dysregulated in the context of tumor cell metabolic 
???????????????????????????????????????????????????????
A reasonable assumption is that during progression 
either gain or loss of function in oncogenes, or tumor 
suppressor genes contributes to the elevated cholesterol 
and steroidogenic phenotype of CRPC [28]. A new 
candidate for this type of regulation is the TERE1 gene 
????? UBIAD1?? ??? ??????????? ?????? ????? ???????????
in this laboratory as absent or diminished in a large 
proportion of prostate, bladder and renal tumors [29-
33]. An overview of TERE1 protein function is shown 
in Fig. 1B. The 338 amino acid TERE1 protein contains 
???? ?????????? ??????????????? ????????? ?? ???????????
(cholesterol recognition amino acid concensus), and 
several solution exposed loops that constitute binding 
interfaces for interacting proteins [32-34]. Protein 
?????????????????????????????? ??????????? ??????????
SOAT1 as TERE1-interacting proteins, strongly suggesting 
a role in cholesterol homeostasis [32-34]. TERE1 sub-
cellular distribution encompasses a range of cholesterol 
regulatory sites including endoplasmic reticulum, golgi, 
and mitochondria. Reconstitution of TERE1 expression in 
bladder, renal, and prostate tumor cell that have silenced 
the endogenous gene results in strong inhibition of tumor 
?????????????????????????????????????????????????????
cause a rare disease of elevated corneal cholesterol and 
lipid deposition called Schnyder’s Corneal Dystrophy, 
SCD [31, 35], and these mutations alter binding to APOE, 
?????? ????????? ?????????????????? ???????????????
by which TERE1 modulates cholesterol homeostasis via 
its direct protein interaction with mediators of synthesis 
??????????????????????????????????????????????????????
?????????????????????????????????????
???? ??????? ?????????????? ??? ?????? ??? ????
prenyltransferase required for vitamin K-2 biosynthesis 
provides a basis for understanding its multi-factorial 
?????????????????????????????????????????????????????????????
TERE1-mediated synthesis of vitamin K-2  clearly affects 
lipid metabolism, redox balance and mitochondrial 
????????? ?????? ????????? ???????? ????????? ??????
cell growth inhibition based on the redox-cycling 
???? ??????????? ??????????? ??? ????????? ???? ???? ?????
suggesting a basis for TERE1 tumor suppressor activity 
????????????????? ?????????? ??? ?????? ????????? ????????
to its mitochondrial localized activity: its Drosophila 
homolog, heix, was found to enhance mitochondrial 
????????? ?????????? ???????? ??????????? ?????? ?? ???????
consistent with the bioenergetics of K-2 in anaerobic 
bacteria and mitochondria [41, 42]. We recently 
reported immuno-electron microscopic localization 
??? ?????? ??? ????????????? ?????? ????? ?????? ???? ????
effects on mitochondrial trans-membrane potential, and 
???? ??????????? ??????????? ???????????? ???? ????? ????




cholesterol biosynthetic pathway. We thus investigated 
TERE1 function as a modulator of the elevated cholesterol 
?????????????????????????????????????????????????????
?????????????????????????????????????????????????????????
?????? ?????? ????????? ??????? ????????????? ?????? ????
???????? ?????? ??? ?? ???? ????? ?????????? ??????????????
cholesterol and steroid accumulation in prostate tumors 
as a means of regulating growth and progression of this 
neoplasm. 
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RESULTS:
TERE1 expression in metastatic prostate cancer:
 To determine the frequency of TERE1 alteration 
in human prostate cancers we conducted an immuno-
histochemical analysis using a custom human prostate 
?????? ???????????????????????????????????????????????
primary carcinoma compared to metastatic specimens. The 
?????????????????????????????????????????????????????????
?????? ?? ????? ??????? ???????? ??????????? ??????????
antibody [33] are summarized in Fig. 2. Overall TERE1 
Figure 1: A. Features of advanced Castrate Resistant Prostate Cancer cells. The elevated cholesterol phenotype of advanced prostate 
???????????????????????????????????????????????????????????????? ??????????????????? ??? ???????????????????? ????????????????????????????
passage and has acquired an altered program of gene expression that permits androgen synthesis. We propose this includes a loss of TERE1 
????????????????? ????????????????????????????????????????????????????????????SXR-mediated mechanisms of regulating sterol accumulation 
?????????????????????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????
APOE is a carrier of vitamin K-1, cholesterol, and triglycerides that interacts with TERE1 and is involved in K-1 delivery as well as lipid 
?????????????????????????????????????????????????? ?????????????????????????????????? ??????????????????????????????????? ????????????
with HMGCR and SOAT1 thus affect cholesterol synthesis and storage. Based on redox-cyling the K-2 and K-3 quinones may create 
????????????????????????? ?????????????????????? ?????? ???????????? ????????????????????????????????????????????????????? ??????????????????
mitochondrial bioenergetics in anaerobic environments. TERE1 synthesis of vitamin K-2 creates a potent endogenous activator of the SXR
??????????????????????????????????????????????????????????????????? ????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????????? ?????????????
an anti-sterol program that may reverse the elevated cholesterol phenotype of CRPC.
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staining was heterogeneous. The most obvious change 
was observed as a loss of staining in the metastatic group. 
TERE1 staining was absent in a quarter of the metastatic 
?????????? ???????? ??? ????????? ??? ????? ?? ????????? ???
?????? ??????? ??? ???????? ??????????? ???? ????? ????????
??????????????????????????????????????????????????????
??????????????????????????????????????????????????????????
??????????? ???? ?????????? ?? ??????????? ?????????? ???
prostate cancer.
Endogenous TERE1 expression and cholesterol in 
C81 cells: 
???? ?????? ????????? ??????? ????? ???????? ????
was derived from its parental cell line, C33 and is a 
widely accepted model for the CRPC phenotype based 
on its ability to become steroidogenic when grown in 
???????? ????? ??????????? ????????????? ????????? ???????
????? ??????????????????????????????????????????????
????????????????????????? ???? ?????????? ??? ????????
?? ????????????? ???????? ?????? ??? ??????? ????? ??? ??????
cholesterol levels of cell lysates were measured using the 
????????????????? ?????????????????????????????????????
to a dilution series of cholesterol standards using equal 
amounts of protein [48]. When we measured the total 
cholesterol levels in C81 cell lysates we found they were 
????????????????????????????????????????????????????
????????????????????????????????????????????????????
cells were grown in lipoprotein-depleted FBS (which 
limits import of serum derived cholesterol), the C33 
??????????????????????????????????????????????????????????
??????????? ?? ???????? ????????? ??? ??????? ??????? ?????
synthesis. In contrast, the cholesterol level in the C81 
cells was only slightly reduced by growth in lipoprotein-
depleted FBS, suggesting they may have an elevated rate 
of cholesterol synthesis. When the cells were cultured in 
????????????????????????????????????????????????????????
cholesterol synthesis, the cholesterol level of the C81 
?????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????
potential for cholesterol synthesis. Overall this suggests a 
correlation between TERE1 levels and cholesterol in the 
C33 and C81 cells, which is consistent with their reported 
????????????????????????????
Elevated cholesterol synthesis: 
The elevated level of total cholesterol in C81 cells 
led us to examine cholesterol synthesis via isotopotomer 
analysis using incorporation of 13?????????? ???? ???
??? ?????????? ????? ???? ???? ???????????????? ????? ????
?????????????????????????????????????????????????????????
????????????????? ??? ??? ????????? ?????????? ???? ???? ???
the areas of 13????????????????????????????????????????
?????? ???????????????? ???? ???????????? ?????? ???????? ???
the total amount of cholesterol isotopomers, was used 
as a measure of cholesterol synthesis. The lysates from 
???? ?????? ??????? ?? ???? ????????? ??? ???? ??????? ???
newly synthesized cholesterol compared to C33 cells. To 
determine the underlying causes of increased cholesterol 
Figure 2: Reduced TERE1 staining in prostate carcinoma tissue micro-array. The representative labeling index groups 
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synthesis we conducted an RTPCR analysis of expression 
of several enzymes involved in cholesterol synthesis and 
????????????? ??? ????????????? ??? ?? ????? ????? ??? ????????
synthesis (Fig 4B). We found that the expression of 
SREBP2, HMGCS, FDPS, HMGCR, STAR, and CYP11A1 
were all elevated in C81 relative to C33 cells. This is 
consistent with the elevated cholesterol synthesis that we 
observe.  
Increased expression of TERE1 protein reduces 
cellular cholesterol levels:
TERE1 protein levels were assessed in two 
additional well-studied prostate cancer cell lines 
originally derived from metastases, DUI45 and PC3, to 
see if reduced levels of TERE1 in cell lines might be a 
feature in common with some metastatic prostate cancer 
??????????????????????????????????????????????????
detectable in either of the cells (Fig. 5). After transfection 
of TERE1 mammalian expression plasmids or adenovirus 
?????????? ??? ??????? ????????? ???????? ??????????? ???
???????????????????????????????????????????????????
then measured total cell-derived cholesterol. As a positive 
???????? ???? ?????? ????? ????????? ???????????? ??????? ???
transfected an expression plasmid for constitutively 
active SREBP1a or SREBP2. In these cells we observed 
an increased cholesterol level with PC-3, and C81, 
respectively, as would be expected. Elevated expression 
????????????????????????????????????????????????????
??????? ?? ????????????? ???????? ?????????????? ????????????
??????????????????????????????????? ????????????????????





conditions, altered  expression of TERE1 can modulate 
cellular cholesterol levels [32, 33, 49]. As a precursor to 
steroid synthesis, cholesterol has important implications 
for prostate cancer and the loss of TERE1 expression may 
be one of the changes acquired during progression to the 
castrate resistant phenotype of advanced prostate cancer.
TERE1 expression is inducible in LnCaP cell 
clones: 
The presence of vitamin D response elements 
(VDREs) within the TERE1 promoter [50], and 
the previously established inhibitory effects of 
??????????????????????????????????????????????????????
52] led us to examine the inducibility of endogenous 




?????????? ????? ???????????? ??? ????? ?????? ????? ????????
although C81 was more sensitive to the cholesterol 
reduction than C33. This further demonstrates that TERE1 
??????????????????????????????????????????????? ?????????
these data suggest the possibility that Vitamin D status in 
humans may affect TERE1 levels and suggest a possible 
therapeutic use of vitamins D and K2 in androgen-
independent prostate cancer. 
Overall our studies have found that either exogenous 
or endogenously induced TERE1 expression can lead to 
changes in cellular cholesterol in prostate cancer cell lines. 
Given the established mechanistic connection between 
vitamin K-2, the product of TERE1 prenyltransferase 
activity, and K-2’s role as a ligand for the SXR nuclear 
receptor, a master regulator of sterol metabolism and 
homeostasis, we next investigated SXR target gene 
expression in the C33 and C81 cell lines.
Figure 3: Endogenous TERE1 expression is reduced 
and cholesterol is elevated in the LnCaP C81 cell model 
of CRPC. ??????????????????????????????????????????????????
a model for the Castrate Resistant Prostate Cancer phenotype 
based on its steroidogenic potential. C81 was derived from the 
parental C33 clone which is not steroidogenic. Immunoblot 
analysis with goat anti-TERE1 antibody showed that C81 
?????????? ?? ???????? ?????? ????????? ???? ???? ?? ???? ?????????
cholesterol level. In lipid free growth media, C33 cholesterol 
???????????????????????????????? ??? ????????????????? ??????????
suggesting C33 is more dependent on transport and C81 more 
????????????? ?????????? ??????? ??????????????????????????? ??????
??????????? ???????? ??? ??????????? ??????? ??? ?? ???????? ???????
than C33 suggesting that C81 cells have a greater potential for 
cholesterol synthesis.
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Figure 4: LnCaP C81 cells have elevated cholesterol synthesis. 4A. We examined cholesterol synthesis in C33 and C81 cell 
???????????????? ?? ??????????? ????????? ?????? ????????????????? 13C-acetate. The sum of the areas of 13???????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????? ??????????????????????????????????????
???????????????????????????????? ?????????????????????????????? ?????????????????????????????????????????? ?????????????? ??????????????
RT-PCR analysis of C81 transcripts relative to C33 revealed elevated expression of several enzymes involved in cholesterol synthesis and 
mobilization of cholesterol to mitochondria. Those genes with an asterix* are established SXR target genes.
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SXR target gene repression in C81 cells:
The steroid and xenobiotic nuclear receptor, SXR, 
has roles in the regulation of endobiotic homeostasis 
(sterols, lipids) and regulation of transporters involved 
in xenobiotic clearance [25, 43]. We assembled a 
comprehensive array of established target genes of SXR, 
of LXR (which can be cross-regulated) and several genes 
involved in the synthesis and catabolism of cholesterol 
and androgens and tested their levels in the cell lines 
???????????????????????????????????????????????????????
??????????????????????? ???????????? ???? ????????????????
in gene expression of C81 cells as a ratio relative to C33 
cells. The differences are depicted with a “+” for fold-
activation and with a “-” for fold-repression. Values 
were normalized as described in methods. Expression of 
genes that are established SXR target genes are indicated 
with an asterix*. The most immediate observation is 
that in C81 cells, the SXR gene itself is expressed at 
??????? ???? ??????? ????? ??????? ?????? ???? ????? ??? ??? ???
SXR? ??????? ?????? ????? ????? ???????? ???????? ????????
????? ??????? ??? ???? ?????????? ??? ?????? ?????? ???? ?????
category of SXR targets are all involved in cholesterol 
?????????????? ????? ????? ???? ?????????? ?????? ?????? ???
cholesterol (CYP7A1*, CYP7B1*, and CYP27A1*). 
???? ????? ???? ????????? ???????????? ?????? ???? ??????????
proteins (ABCB1*, ABCG1*, SRB1*, CD36*, APOE, 
???? ????????????????????????????????????????????????????
TERE1-mediated reductions in expression of these two 
sets of genes could contribute to the elevated cholesterol 
observed in C81 cells via the sum of multiple mechanisms 
??????????????????????????????????????????????????????????
mechanisms, we do observe that the ABCA1* cholesterol 
Figure 5: TERE1 protein expression decreases the cellular cholesterol levels in PC-3, DUI45 and LnCaP-C81 prostate 
cancer cell lines. ???????????????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????? ?????????????????????????
????????????????????????????????????????? ???????? ????? ???????? ??????????????????????????????????????? ???????????????????LACZ Vector 
?????????? ????????????????????????????????????????????????????????????????????????????????????????????????????
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transporter is activated in C81, underscoring the cell’s 
?????????? ??? ????????? ??? ?????? ?????????? ??? ?????
cholesterol levels below a toxicity threshold.) Another 
set of repressed genes play a role in steroid catabolism 
(AKR1C1*, UGT2B17*, UGT2B15*, and HSD17B2) and 
includes several SXR targets. The expected effect would 
be to stabilize androgen production and is consistent with 
the steroidogenic potential of C81. We also note that the 
AR target gene PSA is also elevated by more than two-
fold. (Under full serum growth conditions steroidogenesis 
?????? ???? ??? ????????? ??? ????? ??????? ??????? ??? ?????
observed repression of SRD5A1, AKR1C3*, and 
CYP17A1*, data not shown). Finally, we see a subset of 
classic SXR target genes involved in lipid and fatty acid 
metabolism is also repressed (HMGCS*, CPT1A*, SCD1*, 
FASN*, CYP24A1*, and SREBP1). Overall, in addition to 
induction of cholesterol synthesis genes, it appears that 
repression of SXR?????????????????????????????????????????????
in the C81 CRPC phenotype by virtue of its potential to 
?????????????????????????????????????????????
TERE1 or exogenous vitamin K-2 switches on an 
anti-sterol suite of SXR target genes: 
????? ??? ????????? ???? ??????? ????????? ???
investigate the potential for TERE1 or vitamin K-2 to elicit 
a change in SXR target gene expression.  We analyzed 
expression from parallel sets of C81 cells that had received 
????????????????????????????????????????????????????
???????????????????????????????????????????????????
(C81-K-2). Interrogating the custom array of genes by 
RTPCR revealed a dramatic reversal in expression of SXR
and its target genes. In Fig. 8 the fold expression change of 
the C81 cells transduced with TERE1, or treated with K-2 
is depicted relative to the C81 vector control. First, SXR
expression is increased 11.3-fold by TERE1 expression. 
Consistently, we see that expression of SXR target* genes 
?????????????? ??? ??????????????????????????????? ????
same genes are also increased by Vitamin K-2 across 
each of the 4 groups. TERE1 or K-2 treatments activate 
the set of classical SXR target genes that regulate fatty 
acid and lipid metabolism (HMGCS*, CPT1A*, SCD1*, 
FASN*, CYP24A1*, SREBP1 and VDR). Highly relevant 
to the reversal of the elevated cholesterol phenotype of 
CRPC, we observed increased expression of cholesterol 
?????????????? ??????? ???? ???????????? ?????? ??????
?????????????????????????????????????????????????????????
???? ?????? ???? ??????? ???????? ???? ???? ???????????????
cholesterol reduction we observe and potentially limit the 
supply of sterol precursors for androgen synthesis. Also 
evident is a dramatic increase in expression of androgen 
catabolic genes (AKR1C1*, SULT2A*, UGT2B17*, 
UGT2B15*, CYP3A4*, and HSD17B2). The predicted 
?????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????
of DHT and its precursors, which could potentially 
decrease AR activation driven proliferation (Fig. 9).
Overall, these data demonstrate that TERE1 
expression can lead to regulation of SXR target genes 
involved in lipid metabolism and is consistent with the 
hypothesis that this is due to activation of SXR by TERE1-
???????????????????????????????????????
DISCUSSION: 
Elevated Tumor cell Cholesterol and Prostate 
Cancer: 
Androgen ablation therapy has been limited by 
the emergence of a “castrate resistant phenotype” in 
????? ????????? ????????? ??????? ?????????? ??????? ?????
demonstrates that androgen dependence may not be 
exhausted by systemic castration and inhibition of 
extragonadal sources of androgen. The demonstration 
of de novo synthesis of androgens from cholesterol 
??????????????????????????????????????????????? ?????????
castrate resistant prostate cancer, CRPC, underscores the 
critical role of intracrine mechanisms as a potential driving 
force in cancer progression in the castrate state [5-9]. The 
focus on cholesterol as an intracrine steroid precursor of 
progesterone in mitochondria is further relevant in light of 
additional studies showing that mitochondrial cholesterol 
levels are frequently elevated in prostate cancers and can 
interfere with membrane associated signaling complexes 
Figure 6: Endogenous TERE1 expression is inducible 
in LnCaP cell clones. ????????????????????????????????????
????? ??????? ????? ??????????????? ???????? ??? ????? ???? ???? ??
???????????????????????????????????????????????????????????????
cell cholesterol. 
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required to trigger early mitochondrial apoptotic events, 
and to regulate important pathways governing cell 
?????????????? ????? ???? ???? ???????? ???? ????? ??????????
pathways now recognized as being cholesterol-dependent: 
?????????????????????????????, and AKT, are well 
????????????????????????????????????????????????????????????
addition to its role as a steroid precursor, cholesterol has 
????????????????? ???????????????????????????????????????
????????????
TERE1 expression in prostate cancer specimens 
and cell lines: 
Our objectives in this study were to gain further 
insights into the role of the TERE1 protein in the 
elevated cholesterol phenotype of advanced Castrate 
Resistant Prostate Cancer, CRPC. Our initial interest 
was precipitated by our earlier demonstration that 
?????? ???????? ???? ???????? ??? ????? ???? ??? ???? ???
human prostate cancer specimens [29, 30]. We have 
also found similar TERE1 expression reduction in renal 
clear cell cancers, another example of a tumor with an 
elevated cholesterol phenotype and in bladder cancer 
[32, 33, 49]. With this prostate cancer study, our TERE1 
immunohistochemical analysis found TERE1 staining was 
reduced or completely absent in over half of 50 primary 
and metastatic specimens. TERE1 expression was absent 
???????????????????????????????????????????????????????
specimens, suggesting further loss of TERE1 during 
progression.  Hence, a reduced expression of the TERE1 
???????? ??????? ????? ?????????? ?????????? ??? ????????????
???????????????????????????????????????????
We also found a reduced TERE1 protein expression 
????????????????????????????????????????????????????
????????? ??? ???? ????????? ?????????? ?????? ????? ??????
??????? ????????? ???? ???????????? ?????????? ????????? ???
????? ????? ?????????? ????? ????????????? ????????? ??????
observations suggest that TERE1 expression may 
represent a liability to prostate tumor cell metabolism 
during progression.
TERE1, Cholesterol and SXR target gene analysis 
in LnCaP-C81 cells:
The relevance of TERE1 loss to the elevated 
cholesterol phenotype of advanced prostate cancer is 
Figure 7: LnCaP C81 cells exhibit reduced expression of SXR and SXR target genes involved in cholesterol and steroid 
catabolism. Fluidigm RT-PCR Taqman assays were conducted to compare expression of SXR target genes in C33 and C81 cells. The 
genes are sorted into functional categories and established SXR target genes are indicated with an asterix *. The fold-differences in gene 
expression of C81 cells are depicted as a ratio relative to C33 with a “+” for fold-activation and with a “-” for fold-repression. SXR and 
14 of 18 SXR target* genes are repressed in C81 cells. Repression of this suite of SXR? ???????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
catabolism.
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further based on previous studies from our laboratory 
and others that have demonstrated the role of TERE1 
as a central modulator of cholesterol homeostasis, at the 
?????????????????????????????????????????????????????????
interacts with: APOE, a cholesterol, triglyceride, and 
vitamin K transport protein, HMGR, a master cholesterol 
biosynthetic regulatory enzyme, and SOAT1, a regulator 
??? ???????????? ???????? ???????? ????? ??? ??????? ??? ????
direct role in vitamin K-2 synthesis, TERE1 activates 
the SXR nuclear receptor, a master regulator of lipid, 
sterol and xenobiotic homeostasis, and drug metabolic 
????????????????????????????????????????????????????????
??? ?? ???????? ??????? ??? ????????? ???? ????????????????
????????????????????????????? ????????????? ????????? ???
oxidative, peroxidative, and reductive metabolism of 
???????????????????????????????????????????????????????
exhibits promiscuous binding to DR-3, DR-4, DR-5, ER-
????????????????????????????????????????????????????????
including those with well-established roles in modulation 
????????????????????????????????????????????????????????
relevance of TERE1-mediated vitamin K prenyltransferase 
????????? ??? ???? ??????????? ??? ???????? ?????????????? ???
a recent study showing that vitamin K-2 analogs with 
increasing number of prenyl groups were more potent 
???????? ???? ????????????? ???????????????? ????????? ?????
????????????????????????????????????????????????????????
???????????? ???????? ???????? ???? ??????? ???? ???? ?????
??? ????????? ???? ?????? ???????? ?????? ???? ??????????? ???
?????????????????? ??????????? ???????????????????????????
????????????????????????????????????????????????????????
Figure 8: Ectopic TERE1 or Vitamin K-2 reactivate an anti-sterol suite of SXR target genes in C81 LnCaP cells 
??????????????????????????????????????????????????????Fluidigm RT-PCR Taqman assays were conducted to evaluate expression 
???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????SXR in C81 cells and each of the SXR target* genes tested in this study. Activation 
of this suite of SXR?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
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Consequently, we have focused our investigation on 
????????????????????????? ???????????????????????????????
?????????????????????????????????????? ?????????????????
?????????? ????? ??? ??????????? ??? ???? ??????????????????
C33 clone, C81 cells had increased expression of 
???????????? ?????????? ???????? ????????? ???????
?????? ???? ???????? ???? ??? ????????? ????????????
synthesis measured via 13C acetate incorporation into 
??????????????????????????????????????????????????????????
???????????????????????????????????????????????????????
includes a panel of cholesterol hydroxylation (CYP7A1*, 
CYP7B1*, and CYP27A1????????????????????????ABCB1*, 
ABCG1*, ?????*, CD36*, APOE?? ??????????????????
as androgen catabolic enzymes (AKR1C1*, UGT2B17*, 
Figure 9: Overview of the Anti-Sterol targets activated by TERE1/vitamin K-2 in C81 LnCaP cells. TERE1 activates SXR
target genes (indicated by stars) that hydroxylate cholesterol (CYP7A1, CYP7B1, CYP27A1????????????????????????????????????????????????
and activates a panel of transporters (ABCA1, ABCB1, ABCG1, SRBI, CD36, APOE, MRP2?? ????????????????????????? ?????? ????? ????
cell. Together these would serve to diminish cholesterol, the major precursor for androgen synthesis. TERE1 also turns on a program of 
androgen catabolic enzymes with the following activities:  CYP3A4????????????????????????????????????????????????????SULT2A sulfonates 
DHT to a form that does not activate the Androgen receptor, HSD17B2 converts Testosterone to estrogen, AKR1C1 catabolizes DHT 
by reduction to the inactive 3b andostanediol, and UGT2B15 and UGT2B17 glucuronidate the 3a andostanediol catabolite of DHT thus 
?????????????????????????????????? ???? ????????????????????? ??????????SXR-driven activities executes an anti-sterol program that opposes 
the CRPC phenotype.
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UGT2B15*, and HSD17B2) and several classic SXR 
target genes involved in lipid and fatty acid metabolism 
(HMGCS*, CPT1A*, SCD1*, FASN*, CYP24A1*, and 
SREBP1??????????????????? ?????????????????????????????
use multiple strategies to preserve the sterol precursors 
and active androgens that their AR-driven proliferation is 
??????????????????????????????????????????????????????
cells, others have reported that ABCA1 is silenced 
??? ????????? ????????????????? ??? ???? ????????? ??????
?????? ?????? ????? ???? ???????? ???? ???? ????????? ?????????
???????????????????????????????????????????????????????
???????????????????????????????????????????????ABCA1* 
remains actively expressed as a way to focus regulation 
of potentially toxic sterol levels to a smaller set of pumps 
for tighter control. All of these changes would serve to 
??????????????????????????????????????????????????????????
to the elevated cholesterol phenotype of CRPC.
Vitamin K2/SXR and Cholesterol and Lipid 
Metabolism:
Our investigation of the role of TERE1 in prostate 
cancer supports the hypothesis of a vitamin K-2 
mechanism for TERE1-mediated cholesterol modulation. 
Upon restoration of TERE1 levels in C81 cells via ectopic 
??????????????????????????????????????????????????????????





????? ???? ???? ??????????? ?????????? ??? ???? ????????
?????????????? ???????? ?????????? ?????????????? ?????? ???
concordance between TERE1 and K-2 in the correlation 
????? ??????????? ??? ???? ???? ?????? ????????? ????????? ??
????????????????????????????? ???????????? ????? ???????
increased by K-2. The set of genes that were repressed in 
the C81 basal state are now all switched on by TERE1: 
these include the cholesterol hydroxylation (CYP7A1*, 
CYP7B1*, and CYP27A1???????????????????????ABCB1*, 
ABCG1*, ?????*, CD36*, APOE?? ???? ??????? ?????
??????????????????????????????? ???????????????????? ????
TERE1-mediated cholesterol reduction we observe. Also 
expected is the increased expression of SXR target genes 
that regulate fatty acid and lipid metabolism (HMGCS*, 
CPT1A*, SCD1*, FASN*, CYP24A1*, SREBP1), thus 
??????????????????????????? ???????????????????????
???? ???????? ???? ??????????? ????? ???????? ????????
??? ???? ??????????? ???? ??? ???????? ??? ?????? ????????? ????
????? ??? ???? ????? ?????????????? ??? ???????????????
?????????????????????????????????????????????????????
???????? ??????????????????????????????????????????????
was demonstrated to increase expression of ABCB1 
????????? ??? ???????????? ?????? ??? ????????????? ?????? ?????
???????????????????????? ??????????? ????????????????
???????????????????????????????????????????? ????????????
3) has also been shown to activate another cholesterol 
??????????????????? ?????????????????? ?????????????
mediated regulation of ABCA1 and ABCG1 involved in 
?????????????????????????????????????????????????????????




also show that TERE1 protein expression can be induced 
endogenously via 1,25-(dihydroxy)-vitamin D3 and result 
in a decrease in cellular cholesterol. This is consistent 
with the presence of VDREs in the TERE1 promoter, the 
?????????????????????????????????????????????????????
and early reports that calcitriol can reduce cholesterol 
???????????????????????????????????????????????????????
??????????? ???????????? ???????? ???????? ?? ??????????
and prostate cancer has evolved over many years of 
epidemiological, cell and molecular studies [81]. The 
active vitamin D metabolite, 1,25-(dihydroxy)-vitamin D3, 
calcitriol, has been demonstrated to slow the progression 
of prostrate cancer to advanced disease and inhibit growth 
of many different prostate cancer cell lines. We noted that 
1,25-(dihydroxy)-vitamin D3 caused a potent induction 
?? ??????????? ????? ???? ??????? ??? ????????????? ??? ???
important mechanism for androgen inactivation [82]. In 
addition to cholesterol, studies have shown that elevated 
?????? ????? ???????? ???? ??? ?????? ????????? ???????
cells, which would further serve a role in anti-androgen 
accumulation [83]. 
TERE1 /Vitamin K2/SXR and androgen catabolism:
The next critical dimension of TERE1-mediated 
expression changes relevant to the CRPC phenotype 
concern the set of anti-androgenic targets of SXR that 
????? ??????????? ????????? ??? ?????? ???? ?????? ???? ????
turned on by TERE1 (AKR1C1*, SULT2A*, UGT2B17*, 
UGT2B15*, CYP3A4*, and HSD17B2??? ???? ????????
are supported by several reports highlighting the 
????????????? ?????? ???????? ?????????????????????????????
???? ??????? ???? ??????? ???????? ???? ?????? ???
play a role in catabolism of DHT (Fig 9.), and reduce 
androgen-dependent growth [84]. AKR1C1 converts 
??????????????????????????????????????????????? ??????
????????? ????????????????????????? ???? ????????????? ???
????????????????????????????????????????????????????????
unable to activate the androgen receptor [84, 85]. Impaired 




??????????????????? ??????????? ??? ???? ???? ???? ?????
?????????????????????????????????????????????????? ????
??????????????????????????????????????????????????????????
and reduce androgenic activity is another target activated 
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??? ??????????? ???????? ????????? ????? ???????????
?????? ??? ????????? ??????? ????????? ?????? ???? ????????
testosterone stimulated proliferation and PSA reporter 
activity [82]. TERE1 activation of CYP3A4 is consistent 
with reports of SXR-induced CYP3A4, which hydroxylates 
testosterone and progesterone leading to inactive 
metabolites and resulted in inhibition of androgen-
???????????????????????????????????????????????????????






The predicted net effect of activity of these TERE1-
???????? ???????? ?????? ??? ???? ??????? ?????????????? ???
????????????? ??????????????????? ????? ??????????????
AR activation driven proliferation (Fig. 9). Recently, 
???????? ????? ???????????????????? ??????????????????????
????????? ?????????? ????????? ?????????? ????? ??????????
??????????? ?????????????????????? ???? ???????????????
?????????????????????????????????????????????????????
??????????????? ?????? ??????????????????????????? ????
??????????????????????????????????????????? ??????????
???????????????????????????????????????????????????????
may directly inhibit AR signaling in addition to the effects 
reducing cholesterol and catabolizing AR-activating 
androgens. 
In summary, we have established a TERE1-
???????????????????????????????????????????????????????
tumor specimens, correlated cholesterol synthesis and 
accumulation in prostate cancer cell lines with TERE1 
exogenous or endogenous expression. Furthermore, we 
????? ??????? ??? ???????????? ?????? ??? SXR target genes 
?????????????????????????????????????????????????????????
???????????????????????????????????????????????????????
are switched on by TERE1  expression and vitamin K-2. 
The loss of TERE1 expression may be a defect that tumors 
???????????????????????????????????????????????????????
to permit elevation of cholesterol and facilitate androgen 
driven progression. We believe TERE1 holds promise as 
a new determinant in cholesterol-mediated progression of 
prostate cancer and an exploitable modulator of androgen 
metabolism to oppose CRPC. 
MATERIALS AND METHODS: 
Cell lines and antibodies: 
???? ?????? ???? ???? ???? ????? ??????? ?????
??????????? ????????? ??? ???? ????????? ??? ????????? ???
??? ?????????? ???? ???????????? ??? ????????? ????????
Center). The PC3 and DUI45 cell lines were obtained 
?????????????????????????????????????????????????????
VA) and grown according to supplier’s instructions. Goat 
anti-TERE1 antibodies were obtained from Santa Cruz. 
???????? ???????? ??????????? ??????????? ???????? ????????
peptide antigens of the human TERE1 (amino acids 229-
242) have been previously described [32, 33, 49]. 
Immunohistochemistry: 
????????????????????????????????????????????????
????????? ??????? ?????????? ????? ?????????????? ???
xylene and rehydrated in graded alcohol with quenching 
of endogenous peroxidase activity by treatment with 
????????????????????????????????????????????????????
???????????????????????????????????????????????????????
?????????????????????????????????????oC. After washes, 
the slides were incubated with biotin-conjugated rabbit 
IgG for 30 minutes followed by streptavidin-conjugated 
peroxidase and 3’3-diaminobenzidine, and counter-
stained with hematoxylin. The representative anti-
TERE1 staining levels were sorted into the four groups 
(absent, low, medium and high) based on the based on the 
assigned labeling index and are displayed in Fig 2. The 
labeling index for each core was derived by multiplying 
the percentage of positive cells by an intensity score (that 
ranged from 0 to 3+). The average value obtained from 





???????????? ???? ?????? ???? ??????????? ???????? ????
?????????????????? ??????????????????????????????????
??????????? ??????????? ???? ????????? ???? ????????? ???
HEK-293A cells following guidelines from Invitrogen 
and tittered via an anti-hexon staining procedure from 
Clontech to >4x108? ??????? ??????????? ????? ??? ????
?????????????????????????????????? ????????????? ?GFP 
expression. All plasmids were sequenced to verify coding 
sequences, point and deletion mutations, reading frames, 
??????????????????????????????????????????????????????
????????? ????? ?????????? ??? ??? ???? ?????????? ??????
(Invitrogen) and evaluated on ethidium bromide stained 
agarose gels.
Transient transfection/expression analysis: 
?????????????????????????????????????????????????????
???????????????????????? ??????????????????????????????
?????? ????????? ?????????? ??????????? ????????? ?????
??????????? ????? ????????? ?????????????? ??? ???? ??????
vector. Cells were grown in 10cm dishes and harvested 
after 1-3 days by washing in ice cold PBS, and scraping 
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in the presence of protease and phosphatase inhibitors to 
freeze cell pellets. Preparation of whole cell extracts, BCA 
protein assay, SDS-PAGE and immunoblotting procedures 
have been described previously [32, 33].
Cholesterol Assay: 
The cholesterol content of cell lysates harvested 
??????????????????????????????? ???? ??LACZ, Ad-TERE1, 




Cholesterol synthesis analysis by LC-MS: 
??????????????????????????????? ?????????????????
????????????????????????????????????????????????????
??????? ???????? ???? ?????? ?????????? ??? ??? ????????????
????????? ?????? ????? ??? ?????? 13??????????? ???? ?????
Cells were washed 2xPBS cold, harvested by scraping 
in TBS with protease inhibitors and pellets were frozen. 
??????????????????????????????????????????????????????
added to the frozen pellets and sonicated on ice for 8’ at 
?????????????????????????????????????????????????????
??????????????????????????????????????????????????????
ml of methyl tertiary-butyl ether. The top organic layer 
?????????????????????????????????????????????????????????
injected into an Agilent 1200 liquid chromatographer and 
analyzed by atmospheric pressure chemical ionization 
??????? ????? ??? ???????? ??????? ??????? ???????????
mass spectrometer. Chromatography conditions were 




additional 3 minutes. The stationary phase was a Zorbax 
???????? ?????????? ???? ?? ???????? ???? ???????????? ?????
???????? ??????????????????????????????????????????????
????????????????????????????????????????????????????
????? ?????????? ????????? ?? ??? ????? ?????????? ???????? ??
??????? ????????? ??????? ???????? ?? ?? ???? ???????????
????????????????????? ??????????????????? ?????????????
??????????????????????????????????????????????????????
?????? ??? ????????? ??????????? ???????????? ????????? ????





incorporated during cholesterol synthesis increases the 
?????????????????????????????????????????????????????????
series of isotopomers containing up to a maximum of 12 
carbons derived from acetate C1 and 15 carbons from C2 
[89]. The number of labeled carbons incorporated from 
13C-acetate in cholesterol is proportional to the rate of 
cholesterol synthesis.
RNA isolation, reverse transcription and Fluidigm 









???? ???? ???????? ???? ????????? ?????? ??????????? ?????
Bioanalyzer (Agilent Technologies, Santa Clara, CA). 
???? ????? ??????????? ???????? ??????? ??????????????????
and Fluidigm RTPCR Taqman expression assays were 
performed using procedures recommended by ABI 
Biosciences and Fluidigm (40) and were performed at 
???????????????????? ????????? ????????? ??? ???????????
described (24). Data was analyzed using the Fluidigm 
???????? ????? ??????????? ????? ????????? ????????? ???
??????????????????????????????????????????????????????
vector control to determine the fold change in gene 
expression. 
Taqman probes: 
All Taqman gene expression assays for RT-PCR 
?????????????????????????????????????????????????
????????? ?????? ????????????????????????? ????????????
Probes were inventoried assays selected to span an exon 
junction and are listed: human BACTIN? ? ????????? ??
GUSB? ? ????????? ?? ??????PPIA? ??????????GAS6 ID: 











???? ?????????????? ?? ABCG1? ???? ???????????????
ABCA1????????????????????ABCB1????????????????
m1, CYP3A4? ?????????????????? AKR1C3 ID: 
??????????????? AKR1C2? ???? ???????????????
AKR1C1????? ??????????????SRD5A1????? ??????????
???? ??????? ???? ??????????????? OATP1B1  ID: 
??????????????? HMGR ? ???? ???????????????
CYP27A1? ? ???? ??????????????? CYP24A1 ID: 
??????????????? CYP17A1? ???? ???????????????
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MRP2 ?????? ??????????????UGT2B15 ??? ???????????
UGT2B17 ??????????????????
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